RE:Sanofi acquires pre-clinical TME modulator for $1.225 BlnBiotech startups are also pursuing new ways to prompt T cell responses. ONCY is already there.
https://medcitynews.com/2021/12/bms-joins-off-the-shelf-cell-therapy-chase-with-alliance-on-immatics-cancer-drug/